Physician
Oncology
Dr. Allen I. Oliff, MD
|
|
Give Review
Allen I. Oliff practices Oncology. He studied medicine at Albert Einstein College of Medicine at Jacobi Medical Center. He received awards:"Elected Member". Allen I. Oliff is a published doctor as well. He has 21 publications published. The latest was: N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.
Publications
- Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
- Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
- A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.
- Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity.
- Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
- Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase.
- Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.
- Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase.
- N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.
- 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
- Pseudopeptide inhibitors of Ras farnesyl-protein transferase.
- Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages.
- Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
- Pseudodipeptide inhibitors of protein farnesyltransferase.
- Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
- Genomes of murine leukemia viruses isolated from wild mice.
- Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus.
- Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.
- A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.
- Adrenal suppression after short-term corticosteroid therapy.
Schools
Albert Einstein College of Medicine of Yeshiva University
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Elected Member
Education
-
Albert Einstein College of Medicine at Jacobi Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Jo Ann Chalal, MD
 This Doctor is OpenDoctor Recommended.
|